Characteristics of an Aeromonas trota strain isolated from cerebrospinal fluid.

Aeromonas are ubiquitous in aquatic habitats. However some species can cause infections in humans, but rarely meningitis. Here we describe the isolation and characterization of an Aeromonas strain from cerebrospinal fluid of a meningitis patient. The isolate, identified as A. trota by biochemical and molecular methods, was susceptible to ampicillin but resistant to cephalothin and cefazolin. Genome sequencing revealed virulence factor genes such as type VI secretion system, aerolysin and lateral flagella. The isolate exhibited swarming motility, hemolytic activity and adhesion and cytotoxicity on HeLa cells. This is the first report of A. trota associated with meningitis and its virulence characteristics.

Utilization of carbon sources by clinical isolates of Aeromonas.

Bacteria in the genus Aeromonas are primarily aquatic organisms; however, some species can cause diseases in humans, ranging from wound infections to septicemia, of which diarrhea is the most common condition. The ability to use a variety of carbon substrates is advantageous for pathogenic bacteria. Therefore, we used Biolog GN2 microplates to analyze the ability of 103 clinical, predominantly diarrheal, isolates of Aeromonas to use various carbon sources, and we verified whether, among the substrates metabolized by these strains, there were some endogenous to the human intestine. The results indicate that Aeromonas present great diversity in the utilization of carbon sources, and that they preferentially use carbohydrates and amino acids as carbon sources. Among the carbon sources metabolized by Aeromonas in vitro, some were found to be components of intestinal mucin, including aspartic acid, glutamic acid, l-serine, galactose, N-acetyl-glucosamine, and glucose, which were used by all strains tested. Additionally, mannose, d-serine, proline, threonine, and N-acetyl-galactosamine were used by several strains. The potential to metabolize substrates endogenous to the intestine may contribute to Aeromonas' capacity to grow in and colonize the intestine. We speculate that this may help explain the ability of Aeromonas to cause diarrhea.

Impact of Aeromonas and diarrheagenic Escherichia coli screening in patients with diarrhea in Paraná, southern Brazil.

INTRODUCTION: A wide diversity of bacterial agents may cause diarrhea, presenting challenges to clinical laboratories to define a diagnosis. Considering that most stool cultures are negative, we screened stool samples from patients with diarrhea for the presence of 14 bacterial enteropathogens, aiming to establish which of them should be included in routine stool analysis. METHODOLOGY: Stool samples from 400 patients with diarrhea were analyzed for the presence of Salmonella, Shigella, Campylobacter, Aeromonas, Plesiomonas shigelloides, Vibrio, Yersinia enterocolitica, and diarrheagenic Escherichia coli using conventional microbiological methods and PCR. Two distinct samples were studied; one included predominantly patients involved in outbreaks, and the other patients of low socioeconomic status presenting sporadic cases of diarrhea. RESULTS: In total, 86 cultures (21.5%) were positive. Mixed infections were found in five patients, leading to recovery of 91 strains of enteropathogenic bacteria: Salmonella Enteritidis (9.2%), Aeromonas (7.2%), diarrheagenic E. coli (5.2%), and C. jejuni (1%). However, Salmonella predominated, with 11.5% frequency in diarrhea outbreaks, while Aeromonas predominated among patients of low socioeconomic status, with 14.6% frequency. CONCLUSION: Aeromonas and diarrheagenic E. coli, which are not routinely screened for, deserve to be included in laboratory screening panels.

Subtilase cytotoxin-encoding subAB operon found exclusively among Shiga toxin-producing Escherichia coli strains.

The presence of subAB was investigated for 3,453 Escherichia coli strains of various pathogenic categories. The occurrence of other virulence genes in subAB-positive strains was investigated. The subAB operon was detected among some Shiga toxin-producing E. coli (STEC) serotypes devoid of eae and carrying ehxA. Most subAB-positive strains also harbored stx2, iha, saa, and lpfA(O113).

Virulence properties and antimicrobial susceptibility of Shiga toxin-producing Escherichia coli strains isolated from healthy cattle from Paraná State, Brazil.

The presence of Shiga toxin-producing Escherichia coli (STEC) strains in feces samples of cattle was determined using the cytotoxicity assay on Vero cells and a screening PCR system to detect stx genes. The STEC isolates were serotyped, tested for antimicrobial susceptibility, and analyzed for virulence genes using multiplex PCR. The verocytotoxin-producing E. coli - reverse passive latex agglutination (VTEC-RPLA) assay was also used to detect Shiga toxin production. The frequency of cattle shedding STEC was 36%. The isolates belonged to 33 different serotypes, of which O10:H42, O98:H41, and O159:H21 had not previously been associated with STEC. The most frequent serotypes were ONT:H7 (10%), O22:H8 (7%), O22:H16 (7%), and ONT:H21 (7%). Most of the strains (96%) were susceptible to all antimicrobial agents tested. Shiga toxin was detected by the VTEC-RPLA assay in most (89%) of the STEC strains. The frequency of virulence markers was as follows: stx1, 10%; stx2, 43%; stx1 plus stx2, 47%; ehxA, 44%; eae, 1%; and saa, 38%. Several strains belong to serotypes associated with human disease, and most of them carried a stx2-type gene, suggesting that they represent a risk to human health. The screening PCR assay showed fewer false-negative results for STEC than the Vero-cell assay and is suitable for laboratory routine.

Detecção de Escherichia coli Shiga Toxigênica (STEC) através da amplificação dos genes Stx / Detection of Shiga Toxigenic Escherichia coli (STEC) by amplification of Stx genes

As Escherichia coli Shiga Toxigênicas (STEC) são patógenos emergentes, causadores de diarréia e doenças graves como colite hemorrágica e síndrome hemolítico-urêmica. As STEC diferenciam-se das demais estirpes de E. Coli pela produção de um ou mais tipos de toxina denominadas toxina Shiga 1 e 2, codificadas pelos genes Stx1 e Stx2, respectivamente. O diagnóstico microbiológico das infecções causadas por STEC é dificultado pelo rápido decréscimo no número de organismos excretados nas fezes após o início dos sintomas e pela diversidade bioquímica e sorológica das estirpes de STEC. O objetivo deste trabalho é estabelecer um protocolo de PCR para a detecção de STEC que seja adequado para a rotina dos laboratórios clínicos. As culturas de estirpes de STEC e outros organismos usados como controles e das amostras de fezes diarréicas foram realizadas em ágar MacConkey e incubadas a 36ºC por 18-24 horas. A extração de DNA foi realizada pelo métoda da fervura. Na PCR foi utilizado um único par de iniciadores, ATACAGAGGGA/GGA/GATTTCGT e CC/ATGATGATGG/ACAATTCAG, capaz de detectar os genes Stx, Stx2 e seus variantes numa mesma reação através da ampliação de um fragmento de DNA de aproximadamente 220 pares de base (pb). A PCR foi realizada em volume de 50ml, contendo 10 ml de DNA, tampão Taq 1X; MgCl2, 1,5mM, dNTP 200mM, iniciadores 1mM cada, Taq DNA polimerase 2U. Empregou-se 1 ciclo de 94ºC por 5 minutos e 35 ciclos de 94ºC por 1 minuto, 47ºC por 30 segundos e 72ºC por 30 segundos, seguidos de 1 ciclo de 72ºC por 10 minutos. Os produtos de amplificação foram detectados através de eletroforese em gel de agarose a 2%. DNA extraído das estirpes de STEC O157:H7 (Stx1, Stx2) e O111 (Stx1) permitiu a amplificação de um fragmento de cerca de 220pb, mas nenhum produto de amplificação foi produzido quando o DNA de E. coli ATCC 25922 e de outros organismos controle não produtores de Stx foi utilizado. Foram analisadas 123 cultura de fezes e 3 apresentaram amplificação do fragmento de DNA de cerca de 220 pb, sugerindo a presença de Stx. O protocolo descrito neste trabalho mostrou-se sensível, específico e adequado ao laboratório clínico.